Skip to content

Ibogaine: all studies

Page 56 of 61: studies 551 to 560 of 610, newest first. Back to the ibogaine overview

Research

An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action

Revista Virtual de Química 2021 Maria Emanuelle Damazio Lima, Isian Santos da Silva, Mariana de Oliveira Leal Desmarais et al. 2 citations

Most of the new developed drugs are natural or analogous products, including those that act on the Central Nervous System. The search for new drugs for the treatment of depression is increasing, in view of the high worldwide incidence of this mental disorder. In this context, tryptophan derivatives have an antidepressant effect due to the presence of indole rings, which give them a similarity...

DOI: 10.21577/1984-6835.20210055 (opens in new tab) Antidepressant Action physics Tryptophan Pharmacology +2

Psychedelic Clinical Studies - Bibliometric Dataset

Figshare 2021 Jeremy Weleff, Teddy J. Akiki, Brian S. Barnett preprint

Dataset for a bibliometric analysis of journal articles reporting findings from clinical studies of the psychedelics 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), ayahuasca, dimethyltryptamine (DMT), ibogaine, lysergic acid diethylamide (LSD), mescaline, MDMA, and psilocybin published from 1965-2018.This data accompanies our article:Bibliometric Analysis of Academic Journal Articles Reporting...

DOI: 10.6084/m9.figshare.17054405 (opens in new tab) Data science Information retrieval

The Problem of Pain

Dissent 2021 Sophie Pinkham 1 citation

The Problem of Pain Sophie Pinkham (bio) White Market Drugs: Big Pharma and the Hidden History of Addiction in America by David Herzberg University of Chicago Press, 2020, 400 pp. Click for larger view View full resolution A worker removes the Sackler name from a building at Tufts University in 2019. (David L. Ryan/The Boston Globe via Getty Images) [End Page 130] Reams have been written about...

DOI: 10.1353/dss.2021.0026 (opens in new tab) Bankruptcy White mutation Law Criminology

A non-hallucinogenic psychedelic analogue with therapeutic potential.

Nature 2021 Lindsay P. Cameron, Robert J Tombari, Ju Lu et al. 468 citations

The psychedelic alkaloid ibogaine has anti-addictive properties in both humans and animals1. Unlike most medications for the treatment of substance use disorders, anecdotal reports suggest that ibogaine has the potential to treat addiction to various substances, including opiates, alcohol and psychostimulants. The effects of ibogaine-like those of other psychedelic compounds-are long-lasting2,...

DOI: 10.1038/s41586-020-3008-z (opens in new tab) Full text (opens in new tab) Addiction treatment Substance use disorders Alcohol seeking Heroin seeking +11

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

Chronic Stress August 12, 2020 Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda et al. 83 citations

Background U.S. Special Operations Forces Veterans are at increased risk for a variety of mental health problems and cognitive impairment associated with military service. Current treatments are lacking in effectiveness and adherence. Therefore, this study examined psychedelic treatment with ibogaine and 5-methoxy-N,N-dimethyltryptamine for trauma-related psychological and cognitive impairment...

DOI: 10.1177/2470547020939564 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Veteran mental health Trauma recovery Cognitive improvement

Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies.

Neuropharmacology December 15, 2019 Talia Zeppelin, Lucy Kate Ladefoged, Steffen Sinning et al. 20 citations

The serotonin transporter (SERT) belongs to the monoamine transporter family, which also includes the dopamine and norepinephrine transporters. SERT is essential for regulating serotonergic signaling by the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. Dysregulation of SERT has been implicated in several major psychiatric disorders such as major depressive...

DOI: 10.1016/j.neuropharm.2019.02.030 (opens in new tab) Full text (opens in new tab) Leut Monoamine transporters Mutagenesis X-ray crystallography +8

Hallucinogens and Their Therapeutic Use: A Literature Review.

Journal of Psychiatric Practice September 1, 2019 Matthew J Begola, Jason E Schillerstrom 20 citations

The exploration of possible therapeutic benefits of hallucinogenic substances has undergone a revitalization in the past decade. This literature review investigated the published literature regarding the psychotherapeutic uses of hallucinogens in psychiatric disorders. The results showed that a variety of substances have been evaluated in the treatment of psychiatric disorders, including...

DOI: 10.1097/pra.0000000000000409 (opens in new tab) Full text (opens in new tab) Psychedelics Hallucinogens Entheogens Psychedelic drugs +12

Plant based assisted therapy for the treatment of substance use disorders part 2 : beyond blurred boundaries.

Cultura y Droga July 1, 2019 Matteo Polit, Fabio Friso, Jacques Mabit 4 citations

Objective. This article aims to offer a vision of the centers at a global level that use derivatives of plants or animals for the treatment of substance use disorders, and to offer a reflection on the concept of drugs as medicinal or toxicant agents depending on the context of use, culture and policy. Methodology. Some practices coming from Africa, Asia, Europe and the Americas were considered,...

DOI: 10.17151/culdr.2019.24.28.2 (opens in new tab) Context archaeology Consumption sociology Psychoactive substance Substance use +2

Conformational dynamics of the human serotonin transporter during substrate and drug binding.

Nature Communications April 11, 2019 Ingvar R Möller, Marika Slivacka, Anne Kathrine Nielsen et al. 92 citations

The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange...

DOI: 10.1038/s41467-019-09675-z (opens in new tab) Full text (opens in new tab) Serotonin transporter Drug action Mass spectrometry

Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents

Plant Toxins 2019 E. A. Carlini, Lucas O. Maia 3 citations

This chapter aimed to provide an overview of the large number of hallucinogens of natural origin. Following a literature review, the following hallucinogens were selected for a detailed description that considered their essential chemical groups: indoleamines ( N,N -dimethyltryptamine, 5-methoxy- N,N -dimethyltryptamine, bufotenine, psilocybin, and ibogaine), phenylethylamines (mescaline),...

DOI: 10.1007/978-94-007-6728-7_6-2 (opens in new tab) Full text (opens in new tab) Hallucinogens Psychedelics Mental disorders Indole alkaloids +1